Orbital Therapeutics
Surveying great inventors and businesses
Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company. We are excited to be in business with you — email us at info@axialvc.com
Orbital Therapeutics develops RNA medicines. Founded in 2022 spinning out of Beam Therapeutics, the focus is on vaccines, immunomodulation, and protein replacement therapies. The business model is premised on collecting IP spanning different RNA modalities and delivery methods and offer almost a one-stop shop.
From a technical perspective, Orbital is bringing technologies together to improve the durability of therapeutic RNA candidates and apply them to a broader range of cell types and tissues. Expanding RNA's purview to more diseases. With the key caveat of excluding siRNA.
